Vimarsana
Biggest News Aggregation in the World

Page 16 - Dec 22 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Dec 22. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Dec 22 Today - Breaking & Trending Today

JULO Appoints Line of Veteran Executives: Aims to Accelerate Fintech Lending Revolution in Indonesia - Vimarsana News

JULO Appoints Line of Veteran Executives: Aims to Accelerate Fintech Lending Revolution in Indonesia

JAKARTA, Indonesia, Dec. 22, 2022 /PRNewswire/ -- Indonesian digital credit service provider, PT. JULO Teknologi Finansial (JULO) has appointed three veteran executives to join its C-suite in the 3rd and 4th quarter of 2022. The hiring includes Ankur Mehrotra as President, Manoj Awasthi as Chief Technology Officer and Nimish Dwivedi as Chief Business Officer. This leadership strengthening has been done to accelerate JULO's core objective of driving the fintech lending revolution in Indonesia, through sustainable innovation and financial inclusion. Appointment of three veteran executives to...

Strengthening Data Center Business Portfolio, TelkomGroup Builds NeutraDC Hyperscale Data Center in Batam - Vimarsana News

Strengthening Data Center Business Portfolio, TelkomGroup Builds NeutraDC Hyperscale Data Center in Batam

Focusing on the Singapore market and its surroundings, the data center is a regional expansion step BATAM, Indonesia, Dec. 22, 2022 /PRNewswire/ -- Vice Minister II of the Ministry of State-Owned Enterprises of the Republic of Indonesia, Kartika Wirjoatmodjo together with Telkom's CEO Ririek Adriansyah, Telkom's Director of Wholesale & International Service Bogi Witjaksono and CEO of NeutraDC Andreuw ThAF inaugurated the ground-breaking of the construction of the NeutraDC Hyperscale Data Center Batam at Kabil Industrial Estate, Batam on Wednesday (21/12). This is the second largest...

Paris EMS Report for Dec. 22, 2022 - Vimarsana News

Paris EMS Report for Dec. 22, 2022

The following report is compiled from an incident list as reported by Paris EMS.

P3 Research secures investment from Genesis Capital to accelerate expansion - Vimarsana News

P3 Research secures investment from Genesis Capital to accelerate expansion

P3 is a leading New Zealand clinical trial site network founded in 1998 With sites in seven locations throughout New Zealand, P3's clients range from large multi-nationals to small biotechs globally Genesis Capital has become the major shareholder of the clinical trials group alongside existing shareholders WELLINGTON, New Zealand, Dec. 22, 2022 /PRNewswire/ -- P3 Research, a leading New Zealand clinical trials site network with seven locations across New Zealand has taken on healthcare specialist private equity firm Genesis Capital as an investor. P3 is one of New Zealand's largest cl...

Related Topics:
New Zealand GeneralNew ZealandMichael CaristoHarmos Horton LuskRichard StubbsGenesis CapitalCrux BiolabsP3 Isa Leading New Zealand Clinical Trial Site Network Founded In 1998 With Sites Seven Locations Throughout3 39s Clients Range From Large Multi Nationals To Small Biotechs Globally Genesis Capital Has Become The Major Shareholder Of Clinical Trials Group Alongside Existing Shareholders WellingtonNew ZealandDec 22022 Prnewswire P3 ResearchA Leading New Zealand Clinical Trials Site Network With Seven Locations Across Has Taken On Healthcare Specialist Private Equity Firm Genesis Capital As An Investor P3 Is One Of 39s Largest Networks Focused Recruitment ExcellenceIgh Quality Data And Streamlined Processes In Phase Two Three Trials For Global Pharmaceutical Sponsors Cros With Its Significant Site Network3 Is Well Known Amongst Sponsors For Its Ability To Provide Patient Recruitment Froma Diverse Cross Section Of The CountryHile Also Granting New Zealanders Across The Country Access To Medications That Would Otherwise Be Difficult Find Or Expensive Investment Builds On Genesis 39s Backing Earlier In Year Into Bioanalytical Laboratory Crux BiolabsS Part Of Continued Focus By The Fund On High Potential Clinical Trials Services Businesses In Australia And New ZealandRofessor Richard StubbsEo Of P3 Research SaidUot New Zealand Has Become Increasinglya Destination Of Choice For The Global Clinical Trials Industry With Genesis Now On BoardE Look Forward To Being Able Further Expand Our High Quality Service Capability With New Sites Catering And Expanded Therapeutic Areas For ClientsHile Increasing Patient Access To The Latest Ground Breaking Therapies Acrossa Broad Range Of Disease States Quot Contract Research Sector Has Seen Accelerated Growth Across Region In Recent Years Thanks Part Importance Placed On Community Based Trials Such As Those Conducted At P3 Clinics For Bringing Breakthroughs Quickly Global Market Alongside Expansion PlansHe Investment From Genesis Will Also Focus On Enhancing Technological And Patient Recruitment Capabilities For P3 To Further Cater The Increased Global Demand Cros Sponsors In Need Of High Quality Clinical Trials Michael CaristoArtner At Genesis Capital Said Quot The Pandemic Has Highlighted Crucial Need For These Kinds Of Organisations In Propelling Medical Advancements Forward Pace Needed To Have Impact Ata Global Scale P3 Research Been Go Leading Clinical Trials Almost Two Decades New Zealand And We 39 Re Excited About Beinga Part Their Next Phase Growth Was Advised By Harmos Horton Lusk Legal Ey Accounting Https Www P3research Co Nz Researchisa Respected Independent Company Dedicated Performing High Quality Studies On Behalf Worldwide Pharmaceutical CompaniesOntract Research Organisations And Individual Researchers About Genesis Capital Https Genesiscapital Com Au Capitalisa Specialist Investment Firm Focused On Building Strong Healthcare Businesses In Australia New Zealand They Are An Active Partner Working Alongside Management To Unlock Growth That Have The Potential Be Industry Leaders
Delta Electronics Thailand to Rejoin the Stock Exchange of Thailand's Prestigious SET50 and SET100 Indices - Vimarsana News

Delta Electronics Thailand to Rejoin the Stock Exchange of Thailand's Prestigious SET50 and SET100 Indices

BANGKOK, Dec. 22, 2022 /PRNewswire/ --Delta Electronics (Thailand) PCL. will rejoin the SET50 Index and the SET100 Index from January 1 to June 30, 2023. The Stock Exchange of Thailand (SET) included Delta Thailand in the SET50 and latest SET100 Stock Review and Revision published on December 20, 2022. Delta Thailand is the only Electronic Components sector SET50 constituent in this latest revision. Delta Electronics Thailand to Rejoin the Stock Exchange of Thailand's Prestigious SET50 and SET100 Indices The SET50 and SET100 are the two primary stock indices of Thailand and were developed ...

Related Topics:
Krung Thep MahanakhonJackie ChangDelta Electronics ThailandPower ElectronicsDelta Electronics IncStock Exchange Of ThailandDelta Electronics Thailand Public CompanyDelta ElectronicsStock ExchangeDelta ThailandElectronic ComponentsElectronics ThailandDelta Thailand PresidentPublic CompanyBest Company Performance AwardPrime MinisterBest IndustryDec 22022 Prnewswire Delta Electronics Thailand Pcl Will Rejoin The Set50 Index And Set100 From January 1 To June 30023 The Stock Exchange Of Thailand Set Included Delta In Set50 And Latest Set100 Review Revision Published On December 20022 Delta Thailand Is The Only Electronic Components Sector Set50 Constituent In This Latest Revision Electronics To Rejoin Stock Exchange Of 39s Prestigious And Set100 Indices Are Two Primary Were Developed Accommodate Issuing Index Futures Options While Providinga Benchmark Investment Calculated From Prices Top 50 100 Listed Companies On Set Terms Large Market CapitalizationIgh Liquidity And Compliance With Requirements Regarding The Distribution Of Shares To Minor Shareholders Mr Jackie ChangDelta Thailand PresidentUot Since Listing On The Set In 1995Elta Thailand Has Earneda Solid Reputation For Esg Excellence And Been Included In The Set 39s Top Indices Sustainability Investment Lists Many Years Delta Reentry Into Both Set50 Set100 2023 Reflects Unwavering Confidence Of Investors Our Company Commitment To Sustainable Development Future Growth Potential Quot Despite Pandemic Global Challenges